210 related articles for article (PubMed ID: 32538776)
1. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
Maixent JM; Pons O; Sennoune SR; Sadrin S
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):211-214. PubMed ID: 32538776
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
3. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
[TBL] [Abstract][Full Text] [Related]
4. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
5.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
6. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of New
Oh JH; Jang YS; Kang D; Chang DK; Min YW
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
[TBL] [Abstract][Full Text] [Related]
8. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
10. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
[TBL] [Abstract][Full Text] [Related]
11. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
Sarkawi M; Raja Ali RA; Abdul Wahab N; Abdul Rathi ND; Mokhtar NM
Sci Rep; 2024 Apr; 14(1):9478. PubMed ID: 38658619
[TBL] [Abstract][Full Text] [Related]
16. Probiotics in the treatment of irritable bowel syndrome.
Saggioro A
J Clin Gastroenterol; 2004 Jul; 38(6 Suppl):S104-6. PubMed ID: 15220671
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
Ducrotté P; Sawant P; Jayanthi V
World J Gastroenterol; 2012 Aug; 18(30):4012-8. PubMed ID: 22912552
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.
Sinn DH; Song JH; Kim HJ; Lee JH; Son HJ; Chang DK; Kim YH; Kim JJ; Rhee JC; Rhee PL
Dig Dis Sci; 2008 Oct; 53(10):2714-8. PubMed ID: 18274900
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
